Pharmacokinetic-Pharmacodynamic Modeling of Testosterone and Luteinizing Hormone Suppression by Cetrorelix in Healthy Volunteers

Journal of Clinical Pharmacology

Volumn 40, Issue 3, 2000, Pages 266-274

  Pechstein, Birgit ^a   Nagaraja, Nelamangala V ^b   Hermann, Robert ^c   Romeis, Peter ^a   Locher, Mathias ^a   Derendorf, Hartmut ^b  

^a Dept of Biol Research Biochemistry   (Germany)

^b UNIVERSITY OF FLORIDA   (United States)

^c ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; DRUG DERIVATIVE; GONADORELIN; HORMONE ANTAGONIST; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BIOAVAILABILITY; BIOLOGICAL MODEL; BLOOD; CHEMICAL PHENOMENA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DEPRESSION, CHEMICAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; IMMUNOENZYME TECHNIQUES; LUTEINIZING HORMONE; MALE; MODELS, BIOLOGICAL; RADIOIMMUNOASSAY; TESTOSTERONE;

EID: 0034146307     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700022008937     Document Type: Article

References (16)

1. Behre HM, Kliesch S, Puhse G, Reissmann T, Nieschlag E: High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men. J Clin Endocrinol Metab 1997;82:1403-1408.
2. Conn PM, Crowley WF Jr: Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991;324:93-103.
3. Gonzalez-Barcena D, Vadillo Buenfil M, Garcia Procel E, Guerra-Arguero L, Cardenas Cornejo I, Comaru-Schally AM, Schally AV: Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, cetrorelix (SB-75). Eur J Endocrinol 1994;131:286-292.
4. Behre HM, Bockers A, Schlingheider A, Nieschlag E: Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men. Clin Endocrinol (Oxf) 1994;40:241-248.
5. Reissman T, Engel J, Kutscher B, Bernd M, Hilgard P, Peukert M, Szelenyi I, et al: Cetrorelix. Drugs of the Future 1994;19:228-237.
6. Leroy I, d'Acremont M, Brailly-Tabard S, Frydman R, de Mouzon J, Bouchard P: A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil Steril 1994;62:461-467.
7. Duijkers IJ, Klipping C, Willemsen WN, Krone D, Schneider E, Niebch G, Hermann R: Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist cetrorelix in healthy female volunteers. Hum Reprod 1998;13:2392-2398.
8. Csernus VJ, Szende B, Groot K, Redding TW, Schally AV: Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist: evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH. Arzneimittelforschung 1990;40:111-118.
9. Gibaldi M, Perrier D: Pharmacokinetics 2d ed. New York: Marcel Dekker, 1982;409-417.
10. Handbook for SCIENTIST:467. Handbook of Scientist, Version 2.0, Micro Math Scientific Software, Salt Lake City, UT, p. 467.
11. Miyatake A, Morimoto Y, Oishi T, Hanasaki N, Sugita Y, Iijima S, Teshima Y, et al: Circadian rhythm of serum testosterone and its relation to sleep: comparison with the variation in serum luteinizing hormone, prolactin, and cortisol in normal men. J Clin Endocrinol Metab 1980;51:1365-1371.
12. Wald JA, Jusko WJ: Corticosteroid pharmacodynamic modeling: osteocalcin suppression by prednisolone. Pharm Res 1992;9:1096-1098.
13. Kiesel L, Runnebaum B: Gonadotropin-releasing-hormon und analoga. Gynaekol Geburtsh Rundsch 1992;32:22-30F.
14. Bajusz S, Kovacs M, Gazdag M, Bokser L, Karashima T, Csernus VJ, Janaky T, et al: Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. Proc Natl Acad Sci USA 1988;85:1637-1641.
15. Klingmuller D, Schepke M, Enzweiler C, Bidlingmaier F: Hormonal responses to the new potent GnRH antagonist cetrorelix. Acta Endocrinol (Copenh) 1993;128:15-18.
16. Juneja HS, Karanth S, Dutt A, Parte P, Meherjee P: Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men. Horm Res 1991;35:89-94.